Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System

Yanhong Deng, Senling Feng, Shengying Shi, Zhongwen Yuan, Zhengrong Mei, Jinjin Yin, Dongdong Jing, Shaozhi Liu · 2026

Read Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System by Yanhong Deng, Senling Feng, Shengying Shi, Zhongwen Yuan, Zhengrong Mei, Jinjin Yin, Dongdong Jing, Shaozhi Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13581969.txt.

Description

Deng and co-authors mine in 2026 a United States adverse event database for the pregnancy safety profiles of two immune suppressing drugs, cyclosporine and tacrolimus. Use of these drugs in pregnancy is rising, so surveillance matters. Four signal detection methods were run, with checks limited to single drug cases.

The database held 761 cases for the first drug and 2,204 for the second. Positive signals numbered 80 and 116. Shared signals covered low birth weight, preterm birth, growth restriction, and pregnancy blood pressure problems. The first drug leaned toward kidney rejection signals, the second toward a clotting vessel disorder. Known kidney and nerve toxicity signals also appeared.

Catalog record

CREATORYanhong Deng, Senling Feng, Shengying Shi, Zhongwen Yuan, Zhengrong Mei, Jinjin Yin, Dongdong Jing, Shaozhi Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13581969

Browse the full library · About the Tower of Babel